Menopausal Hormone Therapy (MHT) discontinuation and shortages November 2024
Australia
Patch Shortages
There are a number of MHTs that are currently unavailable. Please note that the TGA has approved some unregistered products under Section 19A and some substitute doses are currently in supply in Australia. Pharmacists are encouraged to contact suppliers Medsurge Healthcare Pty Ltd on 1300 788 261 for orders of Estramon and Sandoz on 1800 726 369 for orders of Estradiol Transdermal System.
Oestradiol patches
|
Expected supply due |
Alternative supply under Section 19A |
|||
|
Dose |
Estradot |
Estraderm |
Estramon |
Estradiol Transdermal System |
|
25 mcg |
31 Dec 2024 |
5 Dec 2024 |
Available |
|
|
37.5 mcg |
30 Jun 2025 |
Available |
Available |
|
|
50 mcg |
31 Jan 2025 |
5 Dec 2024 |
Available |
Unavailable |
|
75 mcg |
31 Jan 2025 |
5 Dec 2024 |
Available |
Unavailable |
|
100 mcg |
31 Dec 2024 |
5 Dec 2024 |
Available |
Available |
Combined patches
|
Dose |
Estalis Sequi |
Estalis Conti |
|
50/140 |
Available |
Available |
|
50/250 |
Available |
Available |
All doses of Climara have been deleted from the market and there will be a reduction in supply until supply is exhausted.
The AMS Guide to MHT Doses (Australia only) provides a guideline to approximately equivalent doses of the different MHT/HRT products in Australia.
New Zealand
As at 21 November 2024, patch availability is provided below.
|
Dose |
Estradot |
Viatris |
Estraderm MX |
|
25mcg |
Low |
Available |
Available |
|
50mcg |
Low |
Available |
|
|
75mcg |
Low |
Available |
|
|
100mcg |
Low |
Available |
More information can be found here
The AMS Guide to MHT Doses (New Zealand only) provides a guideline to approximately equivalent doses of the different MHT/HRT products in New Zealand.